Policymakers and Payers

Provides an overview of the current prior authorization landscape, including the status of electronic prior authorization adoption; the toolkit also looks ahead to the future of prior authorization and industry efforts and changes that will create a more efficient process.

Provides lessons learned from organizations with established MAT programs, including making the business case for MAT, securing buy-in from staff, overcoming community resistance, paying for MAT, finding prescribers, obtaining licenses and credentials, screening and assessing patients, combining medication and therapy, and sustaining a MAT program.

Describes eight evidence-based practices aimed at increasing prescriber use of prescription drug monitoring programs.

Provides general information about evidence-based practices that have been successfully implemented in the United States and are effective in reducing rates of opioid overdose.

Presents information about Medicaid coverage of MAT for opioid and alcohol dependence; covers treatment and cost-effectiveness and includes examples of innovative approaches in Vermont, Massachusetts, and Maryland

Guides States, Tribes, and local communities on best practices for collaborative treatment approaches for women with SUDs. Highlights data on the effects of opioids on pregnant women and the risks and benefits associated with MAT.

Explores ways to expand the use of evidence-based treatment for OUD.

Offers a campaign to inform the public about civil rights protections that may apply to a person in recovery from an opioid use disorder and ensure that covered entities are aware of their obligation to comply with Federal nondiscrimination laws.

Explores the tension between efforts to address the opioid epidemic and the resulting impact on access to pain medications for people facing serious illness; examines the unintended consequences of the responses to the opioid epidemic for patients, families, communities, and clinicians; and considers potential policy opportunities to address them.

Provides a comprehensive array of services, support, resources, and strategies to PDMPs, Federal partners, and other stakeholders to further the efforts and effectiveness of PDMPs in combating the misuse, abuse, and diversion of prescription drugs.